{"name":"Xiaofeng Chen","slug":"xiaofeng-chen","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE9MeXQxN0o5S2FvQWk5RVU4QzRiNEtiMEdtRHVOR19YZHpoVnZ4ZWpSdXVVT053VTQ1dmZlWE9BTGQ3S1ZxdExnR1ZhTkFVd0llRGtmTDBSZS12Z2RGR3d4VTA2ZjN0YnUxc0hDSktmTQ?oc=5","date":"2024-06-17","type":"pipeline","source":"Wiley Online Library","summary":"Platelet-Drug Conjugates Engineered via One-step Fusion Approach for Metastatic and Postoperative Cancer Treatment - Wiley Online Library","headline":"Platelet-Drug Conjugates Engineered via One-step Fusion Approach for Metastatic and Postoperative Cancer Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBuNk5Kc3ltUXAzUzJxMktuNnRpZWlueHdNTlllTHpBdUJLaFQ1VGQzOG1QcUtmLTJuSUdSaVhlT0RJQXJNSGh1a1dicjZGVTd0dzR3VGw0MEJQak80WTNj?oc=5","date":"2024-03-25","type":"trial","source":"Nature","summary":"First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study - Nature","headline":"First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric ca","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTFBURVlJdE1rTUFic040ZUV6U0t3RWhmS1lZbktGRkw2aWxxWEJLVngwbGtfdWJ0cHB5a3dMWjJtN1hqWkcwcDJ3TWFqNEJXSHMzMjZycXJSdGdRaThIdHZncC0zWWVXN2lIYnJjUDRUUQ?oc=5","date":"2023-06-02","type":"pipeline","source":"Wiley Online Library","summary":"Salivary analysis: An emerging paradigm for non-invasive healthcare diagnosis and monitoring - Wiley Online Library","headline":"Salivary analysis: An emerging paradigm for non-invasive healthcare diagnosis and monitoring","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQTWlmLUhxVzRZZFRud0Voby12eTliRFd5Mk9MT1RDOTJQVU96aXBsZU1rOEJHV04zWEZZNTRKUG9OTzQzakVqZ2pVRm5keGhySnpUeFpUaXpWdWJHZ0NJcmNJRmUwRDZhXzdCZjFINGlteTMxelN6RFNfOGllMUxUNUlSc05HT09SZlNaZFNsbExPTlRFUlRNQTdpSzZ3MEtDTFhSS0RjQng0bTJrS28yeXVSdHFqRWs1MGczWk5n?oc=5","date":"2019-10-19","type":"pipeline","source":"Reuters","summary":"China's indebted HNA group names chairman's son as president: Caixin - Reuters","headline":"China's indebted HNA group names chairman's son as president: Caixin","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}